leyu·乐鱼(中国)官方网站-登录入口-登录入口-Powered by Discuz!

U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY™)

2024-01-04
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School

2023-12-26
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates

2023-12-19
Beihai Biotech Secures “Drug Manufacturing Certificate”

2023-06-15
Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023

2023-06-12
Powered by Discuz!用于治疗晚期三阴性乳腺癌的创新药物BH009获批开展II期临床试验

2023-04-10
Powered by Discuz!BH009新药项目在晚期头颈部鳞癌和卵巢癌患者中的I期临床试验完成首例患者给药

2023-03-09
Powered by Discuz!用于治疗非肌层浸润性膀胱癌BH011新药项目II期临床研究完成首例患者给药

2023-03-06

c7游戏官网（中国）责任有限公司 | 千亿官方网页版登录入口(中国)有限公司 | 九州官方网站（中国）有限公司 | 风云体育(中国)官方网站 | emc易倍（中国）有限公司官网 | 千赢国际体育|(中国)有限公司 | e体育app（中国）官方网站 | 华会体育 | 华体网_华体(中国)有限公司官网 |